OCANF
OceanaGold Corp
$25.03
-4.28%
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
May 1, 2026
SEC
OceanaGold filed its audited financial statements for FY2025 via Form 6-K, re-filing to include previously omitted audit
6-K — Impact 3/10
Apr 29, 2026
SEC
OceanaGold released its 2025 Sustainability Report highlighting further improvements in safety (36% reduction in injury
6-K — Impact 2/10
Apr 16, 2026
SEC
OceanaGold announced the release date for its first quarter 2026 financial results and details for its upcoming annual g
6-K — Impact 3/10
Analyst Ratings
2Strong Buy
11Buy
2Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 2.8/10.
NEUTRAL
6-K
3/10
OceanaGold filed its audited financial statements for FY2025 via Form 6-K, re-filing to include prev
May 1, 2026
NEUTRAL
6-K
2/10
OceanaGold released its 2025 Sustainability Report highlighting further improvements in safety (36%
Apr 29, 2026
NEUTRAL
6-K
3/10
OceanaGold announced the release date for its first quarter 2026 financial results and details for i
Apr 16, 2026
NEUTRAL
6-K
3/10
OceanaGold Corporation has commenced trading on the New York Stock Exchange (NYSE) under the ticker
Apr 7, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 87% buy across 15 analysts — 2 strong buy, 11 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.7B | 105.1% | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $2.9B | 54.3% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $2.7B | -6.3% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 11 | 2 | 0 | 0 | 87% | |
| May 1, 2026 | 2 | 11 | 2 | 0 | 0 | 87% | |
| Apr 1, 2026 | 2 | 11 | 2 | 0 | 0 | 87% | |
| Mar 1, 2026 | 2 | 11 | 2 | 0 | 0 | 87% | |
| Feb 1, 2026 | 2 | 12 | 1 | 0 | 0 | 93% | |
| Jan 1, 2026 | 2 | 10 | 2 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.